Marshall Wace Asia’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,255,340
Closed -$86M 108
2019
Q1
$86M Buy
1,255,340
+203,302
+19% +$13.1M 2.6% 12
2018
Q4
$62.6M Buy
+1,052,038
New +$65.8M 2.3% 16
2018
Q3
Sell
-648,129
Closed -$42M 93
2018
Q2
$42M Sell
648,129
-680,836
-51% -$44.5M 1.39% 27
2018
Q1
$95.3M Buy
1,328,965
+226,464
+21% +$16.3M 2.94% 8
2017
Q4
$83.2M Buy
1,102,501
+749,124
+212% +$54.7M 2.87% 7
2017
Q3
$25.8M Sell
353,377
-165,446
-32% -$11.9M 1.22% 29
2017
Q2
$38.4M Buy
518,823
+484,670
+1,419% +$36M 1.97% 24
2017
Q1
$2.49M Buy
+34,153
New +$2.39M 0.15% 48

Other funds holding CL

Marshall Wace Asia's CL Position: Q2 2019 in Review

Marshall Wace Asia sold out of Colgate-Palmolive (CL) in Q2 2019, closing a stake of 1,255,340 shares — an estimated $86M sold.

Marshall Wace Asia first reported a position in CL in Q1 2017 and held it in 8 quarters. The position peaked at $95.3M in Q1 2018. 1,457 funds tracked by Wall St. Rank hold CL as of Q2 2019.

  • Marshall Wace Asia reported no remaining Colgate-Palmolive position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace Asia sold 1,255,340 Colgate-Palmolive shares in Q2 2019, an estimated $86M.
  • Marshall Wace Asia first reported a position in Colgate-Palmolive in Q1 2017 and held it in 8 quarters.
  • Marshall Wace Asia's Colgate-Palmolive position peaked at $95.3M in Q1 2018.
  • 1,457 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2019.

Based on Marshall Wace Asia's 13F filing for Q2 2019, filed 14 Aug 2019.